Finistere leads $5.3m raise for biotech company

ZeaKal will use the money to begin testing on genetically modified soy with potentially enhanced photosynthetic abilities.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.